Skip to content

A model-based RSA Randomized Control Trial to evaluate the stability of the cementless Taperloc hip stem in four different treatment groups.

A model-based RSA Randomized Control Trial to evaluate the stability of the cementless Taperloc hip stem in four different treatment groups. - TAPHIP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45008
Enrollment
80
Registered
2014-02-12
Start date
2014-06-27
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

joint wear osteoarthrosis

Interventions

All patients will receive a total hip prosthesis because of their invalidity and health problems which will be monitored by model-based RSA analysis. Four different hip prostheses will be used.

Sponsors

Haaglanden Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Noninflammatory degenerative joint disease including osteoarthritis, avascular necrosis and rheumatoid arthritis. - Correction of functional deformity. Additional inclusion criteria include: - Male or female - > 18 and

Exclusion criteria

Exclusion criteria: - Any active infection, sepsis or osteomyelitis; standard contraindications for elective surgery - Uncooperative patient or patient with neurologic disorders who are incapable of following directions - Osteoporosis or osteomalacia as assessed during preoperative planning. - Metabolic disorders which may impair bone formation - Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, which cannot be explained by other comorbidity - Vascular insufficiency, muscular atrophy or neuromuscular disease.

Design outcomes

Primary

MeasureTime frame
Primary endpoint is implant stability (measured with Model-based RSA) at 2 years follow-up.

Secondary

MeasureTime frame
Secondary endpoints are implant stability and development (early or late ingrowth) during the pre-defined follow-up periods, standard radiographic parameters which include qualitative femoral and acetabular findings as well as position of the stem and cup, clinical outcomes measured with patient reported outcomes. Other clinical data about the procedure intraoperative/surgical data, survivorship and adverse events will be routinely monitored.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026